Public
黑料正能量 Association content that is available to the public and all website users.
For nearly 30 years, the 340B Drug Pricing Program has provided financial help to safety-net hospitals to manage rising prescription drug costs. Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted鈥
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and鈥
Each year we review a slew of health care outlooks and, after sifting through them, here are a few of the more interesting hypotheses.
Laura J. Stone's latest offering in her three-volume series 鈥淎 Pocket Guide to Purpose鈥 provides a road map for driving team performance and efficiency.
January 27, 2025Jeff WuActing AdministratorCenters for Medicare & Medicaid Services7500 Security BlvdBaltimore, MD 21244Re: CMS 4208-P, Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program,鈥
In the first Leadership Dialogue of 2025, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, talks with two policy experts at the AHA 鈥 Stacey Hughes, executive vice president of government relations and public policy, and Ashley Thompson, senior vice president of鈥
Nonprofit hospitals are exempt from federal and some state and local taxes. Therefore, in addition to providing that 24/7 care, they must meet the Internal Revenue Service (IRS) Community Benefit Standard and publicly and extensively report the range of benefits and services they provide to their鈥
The AHA strongly opposes site-neutral payment cuts, which would reduce access to critical health care services, especially in rural and other underserved communities.
n this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what Englewood Health is doing to prevent opioid use in its communities.
A follow-up to Baxter鈥檚 communication on December 13, 2024 regarding increases in allocations for several U.S. IV products,